Filing Details
- Accession Number:
- 0001127602-19-033198
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-19 16:08:37
- Reporting Period:
- 2019-11-15
- Accepted Time:
- 2019-11-19 16:08:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1560152 | A. John Fallon | C/O Insulet Corporation 100 Nagog Park Acton MA 01720 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-11-15 | 5,000 | $21.35 | 18,469 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-11-15 | 5,000 | $180.07 | 13,469 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-11-18 | 5,525 | $27.37 | 18,994 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-11-18 | 4,000 | $30.04 | 22,994 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-11-18 | 9,525 | $181.41 | 13,469 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-11-15 | 5,000 | $0.00 | 5,000 | $21.35 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-11-18 | 5,525 | $0.00 | 5,525 | $27.37 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-11-18 | 4,000 | $0.00 | 4,000 | $30.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2022-11-01 | No | 4 | M | Direct | |
0 | 2025-05-13 | No | 4 | M | Direct | |
0 | 2023-06-03 | No | 4 | M | Direct |
Footnotes
- The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $181.18 to $182.82. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% of the total award vesting on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant.
- This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2016, 25% of the total award vesting on April 30, 2017 and 25% of the total award vesting on April 30, 2018, subject to continued service as a director or consultant.
- This option is subject to the following vesting schedule: 50% of the total award shall vest on April 30, 2014, 25% of the total award shall vest on April 30, 2015 and 25% of the total award shall vest on April 30, 2016, subject to continued service as a director or consultant.